- Raw Material: 1.5mg HGH Fragment 176-191 + 0.6mg of MOD GRF (1-29)
- Manufacturer: LIFETECH LABS
- Package: 10 vials (2.1mg per vial)
10 vials of 2.1mg. Each vial of 2.1mg consists of 1.5mg HGH Fragment 176-191 + 0.6mg of MODIFIED GRF (1-29).Composition : Box of 10 Bottles of 2.1mg / bottle.Peptides Each vial of 2.1mg consists of 1.5mg HGH Fragment 176-191 + 0.6mg of MODIFIED GRF (1-29).Dilution : use 2ml of bacteriostatic waterFrequency : 2 injections per day (before breakfast or 15-30 minutes before cardio and before bed)Cycle time with a box : 1 monthsCycle time recommended : Minimum of 3 months and maximum of 6 monthsDose vial : 6 X 350 mcg (1 vial for 3 days)Dose injection : 350 mcg (250 mcg HGH FRAG 176-191 + 100 mcg Modified GRF (1-29))Dose in your insulin syringe : = 350 to 0.33 mcg mL (33 units on insulin syringe)BIOSYNERGY SLIM FIT® UNIQUE PEPTIDE BLEND CONCEPTLifetech Labs has combined the 2 most effective peptidesHGH FRAG 176-191 + Modified GRF (1-29)to create the most powerful peptide blend for fat loss.PEPTIDE 1 - HGH FRAG 176-191HGH Fragment [176-191] (also known as HGH Frag) is a modified form of amino acids 176-191 of the human Growth Hormone (GH) polypeptide and is mainly designed for fat loss. HGH Frag breaks down fat in the body and also stops food turning into fat. HGH Fragment [176-191] has several beneficial features: it reduces abdominal fat (in particular visceral fat), without compromising glycemic control. It also increases muscle mass and improves the lipid profile.In summary, the HGH Fragment [176-191]: - Reduces abdominal fat - Increases energy expenditure - Improves lipid profiles and lipolytic activity - Does not have a negative impact on blood glucose or on cell proliferation as growth hormone - Is a fat burner extremely powerful and effectivePEPTIDE 2 - Modified GRF (1-29)Modified GRF 1-29 (GHRH) CJC1295 Growth Hormone Releasing Hormone (GHRH) CJC-1295 is a synthetic secretagogue which stimulates HGH release. In the human body, large amounts of growth hormone are stored in the pituitary. GHRH affects the number of secreting cells and the amount they are able to secrete. Modified GRF 1-29 was invented by ConjuChem, a Canadian biotechnology company. It has a very short acting half-life of about 30 minutes. It is a modified version of the shortest fully functional fragment of Growth-hormone-releasing hormone often referred to as Growth hormone Releasing Factor (1-29) abbreviated as (GRF (1-29)) also known by its pharmaceutical name Sermorelin™.